T. Rowe Price Investment Management Inc. lowered its stake in Revvity Inc. (NYSE:RVTY – Free Report) by 0.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 22,447,103 shares of the company’s stock after selling 54,137 shares during the quarter. Revvity accounts for about 1.4% of T. Rowe Price Investment Management Inc.’s portfolio, making the stock its 12th biggest holding. T. Rowe Price Investment Management Inc. owned 0.20% of Revvity worth $2,171,758,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in RVTY. CYBER HORNET ETFs LLC acquired a new position in Revvity during the second quarter worth $32,000. Cromwell Holdings LLC grew its position in shares of Revvity by 141.4% in the fourth quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock valued at $33,000 after purchasing an additional 198 shares during the period. MUFG Securities EMEA plc acquired a new stake in shares of Revvity in the second quarter valued at about $34,000. Headlands Technologies LLC purchased a new stake in shares of Revvity during the second quarter worth about $49,000. Finally, Los Angeles Capital Management LLC purchased a new stake in shares of Revvity during the fourth quarter worth about $51,000. Hedge funds and other institutional investors own 86.65% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on RVTY shares. Stifel Nicolaus decreased their price target on shares of Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research note on Wednesday, May 6th. TD Cowen boosted their price objective on Revvity from $115.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, May 6th. Barclays increased their target price on Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. The Goldman Sachs Group lowered their price target on Revvity from $110.00 to $95.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 14th. Finally, JPMorgan Chase & Co. dropped their price target on Revvity from $96.00 to $90.00 and set a “neutral” rating for the company in a research report on Wednesday, May 6th. Four equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $107.73.
Revvity Stock Performance
NYSE:RVTY opened at $100.47 on Friday. The company has a market cap of $11.21 billion, a P/E ratio of 48.07, a P/E/G ratio of 2.14 and a beta of 1.11. Revvity Inc. has a twelve month low of $81.22 and a twelve month high of $118.30. The company’s 50-day moving average price is $95.82 and its 200-day moving average price is $97.60. The company has a current ratio of 1.72, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37.
Revvity (NYSE:RVTY – Get Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.02 by $0.04. The company had revenue of $711.12 million during the quarter, compared to analysts’ expectations of $704.07 million. Revvity had a net margin of 8.26% and a return on equity of 8.00%. Revvity’s revenue was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.01 EPS. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, sell-side analysts forecast that Revvity Inc. will post 5.25 earnings per share for the current fiscal year.
Revvity Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be given a $0.07 dividend. The ex-dividend date is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s dividend payout ratio is 13.40%.
Revvity Profile
Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.
Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.
Featured Stories
- Five stocks we like better than Revvity
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Want to see what other hedge funds are holding RVTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity Inc. (NYSE:RVTY – Free Report).
Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.
